Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

300
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
300
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

438
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
438
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

233
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
233
Randomized Experiments01:13

Randomized Experiments

7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MT<sup>2</sup>-CSD and LLM-CRAN: A new dataset and an LLM-based multi-semantic knowledge fusion model for conversational stance detection.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Prenatal NSAIDs exposure and childhood kidney disease: a systematic review and meta-analysis.

Frontiers in pediatrics·2026
Same author

Photophysics of Iodine-Substituted Oxyluciferins: Observation of Simultaneous High Fluorescence Quantum Yields and Singlet Oxygen Sensitization.

Journal of the American Chemical Society·2026
Same author

Identifying the Best Predictive Biomarker in Pharmacogenomics Through Multiple Comparisons With the Best.

Biometrical journal. Biometrische Zeitschrift·2026
Same author

GEiPRS: a fast and powerful machine learning method for polygenic risk score prediction by leveraging genotype-environment interactions.

Briefings in bioinformatics·2026
Same author

Cumulative evidence for the association between maternal hypertension and cleft lip and palate in offspring: a systematic review and meta-analysis.

Frontiers in oral health·2026

Related Experiment Video

Updated: Aug 2, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Learning from real world data about combinatorial treatment selection for COVID-19.

Song Zhai1,2, Zhiwei Zhang3, Jiayu Liao4

  • 1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ, United States.

Frontiers in Artificial Intelligence
|April 20, 2023
PubMed
Summary

Optimal COVID-19 treatment combinations vary by patient characteristics. This study found that age, blood pressure, and C-reactive protein levels influence the best drug combinations for treating coronavirus disease 2019 (COVID-19).

Keywords:
COVID-19G-computationmultiple comparisons with the bestsubgroup analysisvirtual multiple matching

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Related Experiment Videos

Last Updated: Aug 2, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Epidemiology

Background:

  • COVID-19 pandemic presents ongoing challenges in patient management.
  • Understanding optimal combinatorial treatments requires consideration of individual patient factors.

Purpose of the Study:

  • To investigate the effectiveness of different drug combinations for COVID-19.
  • To identify patient characteristics that influence treatment outcomes.

Main Methods:

  • Observational study of 417 COVID-19 patients in Southern China.
  • Virtual multiple matching used to adjust for confounding factors.
  • Comparison of treatment failure rates across various drug combinations and patient strata.

Main Results:

  • Treatment effects for COVID-19 were substantial and heterogeneous.
  • Optimal drug combinations varied based on patient age, systolic blood pressure, and C-reactive protein levels.
  • A stratified treatment strategy was developed based on these baseline characteristics.

Conclusions:

  • Personalized treatment strategies for COVID-19 are crucial.
  • Further validation is needed for the proposed stratified treatment approach.